Market Analysis: Global STD Testing Market
The global STD testing market is expected to reach USD 42.73 billion by 2025, from USD 21.86 billion in 2017 growing at a CAGR of 8.6% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic year2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Market Definition: Global STD Testing Market
A group of sicknesses that can be transmitted starting with one individual then onto the next through the sharing of body liquids, vaginal liquids, blood etc is known as STD (Sexually Transmitted Diseases). Sexually transmitted disease incorporates more than 25-30 irresistible illnesses that are spread through sexual exercises. In absence of treatment or mindfulness these infections can prompt significant medical issues, for example, not having the capacity to get pregnant (fruitlessness), lasting cerebrum harm, coronary illness, growth, and even passing as STD has no early indications. A man presented to STD must experience a finding for sexually transmitted maladies in a doctor’s facility or a wellbeing center. Regular sexual transmitted illnesses incorporate human immunodeficiency infection, chlamydia, gonorrhea, syphilis, herpes simplex infection, human papilloma infection etc. According to the World Health Organization (WHO), more than 1 million STD are acquired every day globally and there are estimated 357.0 million new infections with STDs chlamydia, gonorrhoea, syphilis and trichomoniasis. Furthermore, more than 500.0 million people to have genital infection with Herpes Simplex Virus (HSV). Hence the increasing STD worldwide will create the opportunity for the STD testing market.
Major Market Drivers and Restraints:
- Growing incidence rates and increasing prevalence rates of STD
- Implementation of national screening programs
- Reimbursement for STDs testing
- Social stigma associated with patients visiting specialized STD clinics.
- Huge proportion of patients infected with STDs in out-of-reach geographic areas.
- Stringent regulatory
Market Segmentation: Global STD Testing Market
By type the global STD testing market is segmented into fingertip chlamydia testing, syphilis testing, gonorrhea testing, herpes simplex virus testing, human papilloma virus testing, human immunodeficiency virus testing, chancroid testing and others.
On the basis of location of testing the global STD testing market is segmented into laboratory testing, Point Of Care (POC) testing and others. Laboratory testing is sub segmented into commercial/private labs and public health labs.
On the basis of testing device the global STD testing market is segmented into laboratory devices, Point Of Care (POC) devices and others. Laboratory devices is sub segmented into thermal cyclers – PCR, lateral flow readers – immunochromatographic assays, flow cytometers, differential light scattering machines, absorbance microplate reader – Enzyme Linked Immunosorbent Assay (ELISA) and others. Point Of Care (POC) devices is sub segmented into phone chips (microfluidics + ICT) and portable/bench top/rapid diagnostic kits.
Based on geography, the market report covers data points for 28 countries across multiple geographies namely North America & South America, Europe, Asia-Pacific Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil among others.
Key Developments in the Market:
- In June 2018, GenMark Diagnostics, Inc. submits its ePlex Blood Culture Identification Gram Positive Panel to FDA for approval.
Competitive Analysis: Global STD Testing Market
The global STD testing market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of STD testing market for global, Europe, North America, Asia Pacific and South America.
Major Market Competitors/Players: Global STD Testing Market
Some of the major players operating in the global STD testing market are Abbott Laboratories, Affymetrix, Inc., Alere Inc., Aposcience AG, BCR Biotech Inc., Becton Dickinson And Company, Biocartis SA, Biomerieux, Bio-Rad Laboratories Inc., Cepheid Inc., Danaher Corporation, DiaSorin, Exogen Biotechnology, Inc., GenMark Diagnostics, Hologic, Inc., OraSure Technologies, Qualigen Inc., Quidel Corporation, Roche Diagnostics, Thermo Fisher Scientific Inc. among others.
Research Methodology: Global STD Testing Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistics and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an analyst call or can drop down your inquiry.
Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.
Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others
Reasons to Purchase this Report
- Current and future of global STD testing market outlook in the developed and emerging markets
- The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
- Regions/countries that are expected to witness the fastest growth rates during the forecast period
- The latest developments, market shares, and strategies that are employed by the major market players
Customization of the Report
- All the segmentation provided above in this report is represented at country level.
- All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization).